Califf Nomination Gets Fishy With Murkowski Hold
This article was originally published in The Tan Sheet
Executive Summary
Senator Murkowski promises a hold on Robert Califf’s nomination for FDA commissioner over the agency’s approval of genetically engineered salmon.
You may also be interested in...
PDUFA Reaches Approval Altitude; Can House Maintain Senate Speed?
After about a week of debate, the Senate overwhelmingly passes its FDA user fee package, with only track and trace to be finalized. House members are scheduled to begin floor debate after Memorial Day in the hopes of sending the bill to President Obama before July 4.
Worries About 180-Day Exclusivity Reforms Persist As User Fee Bill Advances
FDA-crafted legislative text emerges that generic industry says could weaken the incentive, but so far no changes are in the draft House and Senate bills.
Surprise US FDA Facility Inspections Resume In India
Unannounced facility visits also were to start again in China, but FDA Commissioner Robert Califf said they have been delayed by the COVID-19 outbreak in the country.